Home » Gimbe, + 28% of first doses to over 50s in 7 days, is an obligation effect – Health

Gimbe, + 28% of first doses to over 50s in 7 days, is an obligation effect – Health

by admin

The recent introduction of compulsory vaccination for over 50s “pushes the first doses” and “begins to show the first effects”: in the week 12-18 January in this age range the new vaccinated were 128,966, equal to +28.1 % compared to the previous week.

Overall, in the same period of time the new vaccinations were 510,742 compared to the 496,969 of the previous week (+ 2.8%) and the new vaccinations in the 5-11 year range are stable (equal to 240,920), which represent almost half of the first doses. This is what emerges from the new monitoring of the Gimbe Foundation.

Furthermore, in 7 days, there was an increase in the total number of total tampons performed (+ 10.8%), which went from 6,926,539 in the week 5-11 January to 7,672,378 in the week 12-18 January, with an increase rapid swabs (+856.687 equal to + 17.8%) compared to a slight decline in molecular ones (-110.848 equal to -5.3%). The 7-day moving average of the positivity rate for molecular swabs is further reduced (from 25.4% to 21.2%), while it remains stable (14.4% vs 14%) for rapid antigenic agents.

Stops the increase in Covid-19 cases, which in 7 days was only 3%. But deaths increased by 49.7% over the same period of time, from 1,514 to 2,266, equal to an increase of 49.7%. This is what emerges from the new monitoring of the Gimbe Foundation, relating to the week from 12 to 18 January which, compared to the previous one, reveals a stabilization of new cases (1,243,789 compared to 1,207,689). The incidence, on the other hand, exceeds 2,000 cases per 100,000 inhabitants in 58 provinces.

See also  Jan Garbarek's sax in the amphitheater of Alba Fucens - Abruzzo

breaking latest news © Copyright ANSA


This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy